Search Results 1651-1660 of 17837 for Substance+dependence

1. Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma - Mayo Clinic

   ... drug, AND must also adhere to the guidelines of any treatment-specific ... Agree to practice effective barrier contraception during the entire study treatment ...

2. Clinical trials - Oncology (Medical)

   The goal of this clinical trial is to learn about the safety of drug \[Ac225\]RTX-2358 and the diagnostic imaging agent \[Cu64\]LNTH-1363S. Additionally Ratio ...

3. Clinical trials - Oncology (Medical)

   The goal of this clinical trial is to learn about the safety of drug \[Ac225\]RTX-2358 and the diagnostic imaging agent \[Cu64\]LNTH-1363S. Additionally Ratio ...

4. An Extension Study Of Subjects Who Received An Avalyn Inhaled Antifibrotic Agent (SAIL) - Mayo Clinic

   ... drug is approved, the participant withdraws from the study, or the study is terminated. New patients will be trained to use the nebuliser at the first ...

5. Oncology (Medical) - Clinical trials

   The goal of this clinical trial is to learn about the safety of drug \[Ac225\]RTX-2358 and the diagnostic imaging agent \[Cu64\]LNTH-1363S. Additionally Ratio ...

6. A Study to Learn More About Asundexian (Also Called BAY2433334) for Prevention of Ischemic Stroke in Male and Female Participants Aged 18 Years and Older Who Already Had Such a Stroke Due to a Blood Clot That Formed Outside the Heart and Travelled to the Brain, or Temporary Stroke-like Symptoms - Mayo Clinic

   ... substance, whichever is longer) before randomization;. • Concomitant use of combined P-gp and strong CYP3A4 inhibitors e.g. human immunodeficiency virus ...

7. A Study to Evaluate the Effectiveness and Safety of Lanadelumab for Prevention Against Acute Attacks of Non-histaminergic Angioedema in Adolescents and Adults - Mayo Clinic

   Dosing with any investigational drug or exposure to an investigational device within 4 weeks prior to screening. Exposure to angiotensin-converting enzyme ...

8. Real-world evidence study of regenerative medicine and shoulder surgery - Mayo Clinic News Network

   To accelerate Food and Drug Administration (FDA) approval of promising ... Taylor Hays, Mayo Clinic Nicotine Dependence Center. Related Articles. Health ...

9. Oncology (Medical) - Clinical trials

   The goal of this clinical trial is to learn about the safety of drug \[Ac225\]RTX-2358 and the diagnostic imaging agent \[Cu64\]LNTH-1363S. Additionally Ratio ...

10. A Study Using the New TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients with Metastatic, Persistent, Recurrent, or Progressive Solid Tumors - Mayo Clinic

    ... drug. Exclusion Criteria: Is pregnant, breastfeeding, or planning a pregnancy; Known standard therapy for the patient's disease that is potentially curative ...